Clinical Trial Update: A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer. [Phase 2]

View source ↗

Summary

Phase II trial update for QL1706 combined with platinum-based chemotherapy in SMARCA4-deficient locally advanced or metastatic non-small cell lung cancer; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum-based chemotherapy (platinum-based chemotherapy)
• QL1706

Snippet

Sponsor: Zhijie Wang | Conditions: SMARCA4-Deficient Tumor, Locally Advanced or Metastatic Non-Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING